Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma

Gold standard in therapy of superficial, non-muscle invasive urothelial tumors is transurethral resection followed by intravesical instillation therapies. However, relapse is commonly observed and therefore new therapeutic approaches are needed. Application of (213)Bi-immunoconjugates targeting EGFR...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Biol Ther
Autori principali: Fazel, Julia, Rötzer, Silvia, Seidl, Christof, Feuerecker, Benedikt, Autenrieth, Michael, Weirich, Gregor, Bruchertseifer, Frank, Morgenstern, Alfred, Senekowitsch-Schmidtke, Reingard
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2015
Soggetti:
Research Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4846129/
https://ncbi.nlm.nih.gov/pubmed/26177233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1071735
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi